William L. Farrar
#143,855
Most Influential Person Now
William L. Farrar's AcademicInfluence.com Rankings
William L. Farrarphilosophy Degrees
Philosophy
#7643
World Rank
#10884
Historical Rank
Logic
#4689
World Rank
#6010
Historical Rank
Download Badge
Philosophy
Why Is William L. Farrar Influential?
(Suggest an Edit or Addition)William L. Farrar's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The role of IL-6 and STAT3 in inflammation and cancer. (2005) (936)
- Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. (1989) (527)
- The Biochemistry, Biology, and Role of Interleukin 2 in the Induction of Cytotoxic T Cell and Antibody‐Forming B Cell Responses (1982) (494)
- Thymoma production of T cell growth factor (Interleukin 2). (1980) (468)
- Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. (1981) (444)
- Visualization and characterization of interleukin 1 receptors in brain. (1987) (440)
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis (2008) (429)
- Activation of Human T Lymphocytes Is Inhibited by Peroxisome Proliferator-activated Receptor γ (PPARγ) Agonists (2000) (381)
- Activation of receptor-associated tyrosine kinase JAK2 by prolactin. (1994) (341)
- Interleukin-2 stimulates association of protein kinase C with plasma membrane (1985) (320)
- Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. (1984) (279)
- Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. (2000) (271)
- Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. (1989) (239)
- The cancer stem cell niche—there goes the neighborhood? (2011) (228)
- Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. (1986) (227)
- Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature (2009) (221)
- Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. (2005) (215)
- Altered cytosol/membrane enzyme redistribution on interleukin-3 activation of protein kinase C (1985) (211)
- Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer (2014) (209)
- Modulating influence on HIV/AIDS by interacting RANTES gene variants (2002) (202)
- Macrophage-independent activation of helper T cells. I. Production of Interleukin 2. (1980) (201)
- Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580 (1996) (180)
- The Immune Logical Brain (1987) (179)
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer (2011) (178)
- Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. (2000) (176)
- The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. (1991) (168)
- JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. (1999) (163)
- Interleukin-6 Regulation of the Human DNA Methyltransferase (HDNMT) Gene in Human Erythroleukemia Cells* (2001) (160)
- Differential Control of the Phosphorylation State of Proline-juxtaposed Serine Residues Ser725 of Stat5a and Ser730 of Stat5b in Prolactin-sensitive Cells* (1998) (159)
- EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis (2012) (156)
- Nitric oxide and thiol redox regulation of Janus kinase activity. (1998) (154)
- The role of arachidonic acid metabolism in the activities of interleukin 1 and 2. (1985) (152)
- Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses. (1980) (143)
- Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. (1994) (138)
- Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. (2008) (135)
- Targeting cancer stem cells with phytochemicals. (2008) (130)
- Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. (1992) (130)
- JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. (1994) (129)
- Association of protein kinase C activation with IL 2 receptor expression. (1986) (127)
- Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells. (2004) (126)
- Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. (2005) (123)
- Tyrphostin AG‐490 inhibits cytokine‐mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen‐activated human T cells (1999) (123)
- Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages. (1978) (122)
- CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis (1987) (122)
- HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. (1989) (121)
- Epigenetic gene silencing in the Wnt pathway in breast cancer (2008) (119)
- Epigenetic Regulation of SOX9 by the NF‐κB Signaling Pathway in Pancreatic Cancer Stem Cells (2013) (114)
- IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase. (2007) (110)
- Activation of Discoidin Domain Receptor 1 Isoform b with Collagen Up-Regulates Chemokine Production in Human Macrophages: Role of p38 Mitogen-Activated Protein Kinase and NF-κB (2004) (105)
- Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells. (2007) (105)
- Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells. (1986) (103)
- Establishment of continuous cultures of Thy1.2+, Lytl+,2−T cells with purified interleukin 3 (1981) (101)
- Cancer stem cells, CD200 and immunoevasion. (2008) (101)
- Interleukin 2 regulates immune interferon (IFN gamma) production by normal and suppressor cell cultures. (1982) (101)
- NF-kappaB activates IL-6 expression through cooperation with c-Jun and IL6-AP1 site, But is independent of its IL6-NFkappaB regulatory site in autocrine human multiple myeloma cells (2004) (100)
- Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. (1995) (100)
- Prolactin Stimulates Serine/Tyrosine Phosphorylation and Formation of Heterocomplexes of Multiple Stat5 Isoforms in Nb2 Lymphocytes* (1997) (98)
- Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. (1995) (98)
- The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors. (1983) (96)
- Effects of the sesquiterpene lactone parthenolide on prostate tumor‐initiating cells: An integrated molecular profiling approach (2009) (95)
- Interleukin (IL)-4 Indirectly Suppresses IL-2 Production by Human T Lymphocytes via Peroxisome Proliferator-activated Receptor γ Activated by Macrophage-derived 12/15-Lipoxygenase Ligands* (2002) (94)
- Gossypol Induces Apoptosis by Activating p53 in Prostate Cancer Cells and Prostate Tumor–Initiating Cells (2010) (94)
- Activation of Estrogen Receptor Blocks Interleukin-6-inducible Cell Growth of Human Multiple Myeloma Involving Molecular Cross-talk between Estrogen Receptor and STAT3 Mediated by Co-regulator PIAS3* (2001) (90)
- In situ hybridization histochemistry localization of interleukin-3 mRNA in mouse brain. (1989) (89)
- BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer (2011) (89)
- Inhibition of Estradiol Receptor/Src Association and Cell Growth by an Estradiol Receptor α Tyrosine-Phosphorylated Peptide (2007) (88)
- Microarray Analysis of Epigenetic Silencing of Gene Expression in the KAS-6/1 Multiple Myeloma Cell Line (2004) (86)
- Interleukin 2 modulation of adenylate cyclase. Potential role of protein kinase C. (1986) (85)
- Genomic profiling of tumor initiating prostatospheres (2010) (85)
- Analysis of Interleukin-2-dependent Signal Transduction through the Shc/Grb2 Adapter Pathway (1995) (81)
- Clinical significance of Polycomb gene expression in brain tumors (2010) (80)
- The emerging role of histone lysine demethylases in prostate cancer (2012) (78)
- Epigenetic gene regulation in stem cells and correlation to cancer. (2009) (78)
- Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor (2004) (77)
- Increased Expression of DNA Repair Genes in Invasive Human Pancreatic Cancer Cells (2011) (75)
- Vasopressin replacement of interleukin 2 requirement in gamma interferon production: lymphokine activity of a neuroendocrine hormone. (1982) (75)
- Stimulation of specific GTP binding and hydrolysis activities in lymphocyte membrane by interleukin-2 (1987) (74)
- Interferon gamma and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines. (1986) (74)
- Two Discrete Regions of Interleukin-2 (IL2) Receptor β Independently Mediate IL2 Activation of a PD98059/Rapamycin/Wortmannin-insensitive Stat5a/b Serine Kinase* (1997) (73)
- Identification of Vitronectin as an Extrinsic Inducer of Cancer Stem Cell Differentiation and Tumor Formation (2009) (73)
- Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer. (2006) (72)
- Cancer stem cell epigenetics and chemoresistance. (2009) (69)
- Targeted disruption of stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven T(H)2 cell response. (2000) (68)
- TGFBR3 loss and consequences in prostate cancer (2007) (67)
- Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines (2007) (64)
- Biochemical and Molecular Events Associated with Interleukin 2 Regulation of Lymphocyte Proliferation (1986) (63)
- Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP. (2007) (63)
- Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase. (1994) (59)
- Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-γ and interleukin-4 receptor-α (1996) (58)
- Activation of JAK3, but Not JAK1, Is Critical to Interleukin-4 (IL4) Stimulated Proliferation and Requires a Membrane-proximal Region of IL4 Receptor (*) (1995) (58)
- Cancer stem cells: potential target for bioactive food components. (2012) (57)
- Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck. (1993) (57)
- Phorbol myristic acetate enhances the production of interleukin 2. (1981) (57)
- Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation (2005) (56)
- Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation. (1993) (53)
- Stem cells in prostate cancer: Resolving the castrate-resistant conundrum and implications for hormonal therapy (2006) (53)
- Pervanadate simulates the effects of interleukin-2 (IL-2) in human T cells and provides evidence for the activation of two distinct tyrosine kinase pathways by IL-2. (1994) (53)
- Functional Uncoupling of the Janus Kinase 3-Stat5 Pathway in Malignant Growth of Human T Cell Leukemia Virus Type 1-Transformed Human T Cells1 (2000) (53)
- Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression. (1987) (51)
- Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells. (2004) (50)
- Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation-attenuated cercariae (1984) (50)
- Epigenetic Silencing of the Human Nucleotide Excision Repair Gene, hHR23B, in Interleukin-6-responsive Multiple Myeloma KAS-6/1 Cells* (2005) (50)
- Interleukin 2 regulation of mitogen induction of immune interferon (IFN gamma) in spleen cells and thymocytes. (1982) (50)
- Histone lysine demethylases in breast cancer. (2013) (49)
- Regulation of expression of the interleukin-2 receptor on hematopoietic cells by interleukin-3. (1986) (48)
- Integrated molecular profiling of SOD2 expression in multiple myeloma. (2007) (48)
- Potentiation of lymphokine-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase. (1988) (48)
- Characterization of Active and Inactive Forms of the JAK2 Protein-tyrosine Kinase Produced via the Baculovirus Expression Vector System (*) (1995) (46)
- STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells (2002) (46)
- Effects of Manganese Superoxide Dismutase Silencing on Androgen Receptor Function and Gene Regulation: Implications for Castration-Resistant Prostate Cancer (2008) (46)
- Identification of a signal-transduction pathway shared by haematopoietic growth factors with diverse biological specificity. (1987) (45)
- DNA Hypermethylation and Partial Gene Silencing of Human Thymine-DNA Glycosylase in Multiple Myeloma Cell Lines (2006) (45)
- Association of the erythropoietin receptor with protein tyrosine kinase activity. (1992) (44)
- Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state. (2004) (44)
- Interleukin 2 and diacylglycerol stimulate phosphorylation of 40 S ribosomal S6 protein. Correlation with increased protein synthesis and S6 kinase activation. (1987) (44)
- 15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits Transcriptional Activity of Estrogen Receptor-α via Covalent Modification of DNA-Binding Domain (2007) (43)
- DNA repair: the culprit for tumor-initiating cell survival? (2011) (42)
- Signal transduction of human interleukin 3 and granulocyte-macrophage colony-stimulating factor through serine and tyrosine phosphorylation. (1990) (41)
- Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells (2010) (40)
- Perturbations in hypoxia detection: a shared link between hereditary and sporadic tumor formation? (2006) (40)
- Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator (2006) (39)
- Androgen Receptor as a Therapeutic Target for Androgen Independent Prostate Cancer (2006) (39)
- Interleukin 2 induction of interferon-gamma mRNA synthesis. (1986) (37)
- Multilineage hematopoietic growth factor interleukin 3 and direct activators of protein kinase C stimulate phosphorylation of common substrates. (1986) (37)
- Interleukin 2 rapidly stimulates synthesis and breakdown of polyphosphoinositides in interleukin 2-dependent, murine T-cell lines. (1987) (35)
- A Role for PPARγ in the Regulation of Cytokines in Immune Cells and Cancer (2008) (34)
- Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis. (2005) (34)
- IL-6 induces expression of the Fli-1 proto-oncogene via STAT3. (2002) (33)
- Structural and mechanistic aspects of Janus kinases: how the two-faced god wields a double-edged sword. (1998) (32)
- Cloning of the gene encoding rat JAK2, a protein tyrosine kinase. (1995) (32)
- Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants. (1987) (31)
- The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen-activated protein kinase activity. (2003) (31)
- Characterization of a 97-kDa phosphotyrosylprotein regulated by multiple cytokines. (1992) (31)
- Cytokine regulation of human immunodeficiency virus expression. (1991) (31)
- Interleukin 2 (IL-2) activity during tumor growth: IL-2 production kinetics, absorption of and responses to exogenous IL-2. (1984) (30)
- Nuclear Receptors as Negative Modulators of STAT3 in Multiple Myeloma (2005) (29)
- Radioresistance and Cancer Stem Cells: Survival of the Fittest (2011) (28)
- Cancer stem cells: the seeds of metastasis? (2008) (28)
- Suppressor cell activity in tumor-bearing mice. II. Inhibition of DNA synthesis and DNA polymerases by TBH splenic suppressor cells. (1978) (27)
- Pharmacogenomics and cancer stem cells: a changing landscape? (2011) (27)
- Targeting prostate cancer stem cells. (2009) (27)
- Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease. (2010) (26)
- 5-Azacytidine treatment of a murine cytotoxic T cell line alters interferon-gamma gene induction by interleukin 2. (1985) (26)
- Functional and genomic analyses of FOXP3-transduced Jurkat-T cells as regulatory T (Treg)-like cells. (2007) (26)
- Inhibition of adenylate cyclase by IL 2 in human T lymphocytes is mediated by protein kinase C. (1987) (26)
- Long‐term recovery of irradiated prostate cancer increases cancer stem cells (2012) (26)
- Characterization of the in vitro kinase activity of a partially purified soluble GST/JAK2 fusion protein (2002) (24)
- Transforming growth factor-beta receptor III downregulation in prostate cancer: is inhibin B a tumor suppressor in prostate? (2007) (23)
- Transcriptional crosstalk between nuclear receptors and cytokine signal transduction pathways in immunity. (2004) (23)
- Structural domains of interleukin-2 receptor beta critical for signal transduction: kinase association and nuclear complex-formation. (1995) (23)
- Interleukin 2 stimulation of protein kinase C membrane association: evidence for IL-2 receptor phosphorylation. (1985) (22)
- Flow cytometry resonance energy transfer suggests an association between low-affinity interleukin 2 binding sites and HLA class I molecules. (1990) (22)
- Androgen receptor expression in prostate cancer stem cells: is there a conundrum? (2008) (22)
- Regulation of human natural cytotoxicity by IgG. II. Cyclic AMP as a mediator of monomeric IgG-induced inhibition of natural killer cell activity. (1988) (22)
- Expression of transfected human interferon-gamma DNA: evidence for cell-specific regulation. (1986) (21)
- In vitro production of immunosuppressive factors by murine sarcoma virus-transformed mouse fibroblasts. (1980) (21)
- Visualization of cytokine and virus receptors common to the immune and central nervous system. (1987) (19)
- Characterization of an interleukin-2 (IL-2)-induced tyrosine phosphorylated 116-kDa protein associated with the IL-2 receptor beta-subunit. (1993) (19)
- CCAAT/Enhancer-binding Protein β Mediates Interferon-γ-induced p48 (ISGF3-γ) Gene Transcription in Human Monocytic Cells* (2001) (19)
- IFN-gamma inhibits c-myc gene expression by impairing the splicing process in a colony-stimulating factor dependent murine myeloid cell line. (1988) (18)
- In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. I. Description of progressive impairment and demonstration of splenic suppressor cells. (1978) (17)
- Regulation of ornithine decarboxylase activity by IL-2 and cyclic AMP. (1988) (17)
- Activating Mutations in STAT3 and STAT5 Differentially Affect Cellular Proliferation and Apoptotic Resistance in Multiple Myeloma Cells (2004) (17)
- Negative regulation of Janus kinases (2007) (15)
- Faithful markers of circulating cancer stem cells: is CD133 sufficient for validation in clinics? (2011) (14)
- Cryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression. (2016) (14)
- Ligand-specific calcium mobilization in IL 2 and IL 3 dependent cell lines. (1986) (14)
- 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. (2007) (14)
- Localization of the T4 antigen/AIDS virus receptor in monkey and rat brain: prominence in cortical regions. (1986) (14)
- Characterization of a class 3 tyrosine kinase. (1992) (14)
- In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. II. Mechanism of inhibition. (1978) (13)
- Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells (2000) (13)
- Identity of common phosphoprotein substrates stimulated by interleukin 2 and diacylglycerol suggests a role of protein kinase C for IL 2 signal transduction (1987) (13)
- Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha. (1996) (13)
- Tyrphostin AG-490 Regulation of as Novel Molecular Targets for the JAK3, STAT, and MAPK Signaling Pathways (1999) (13)
- Detection of low and high affinity binding sites with fluoresceinated human recombinant interleukin-2. (1989) (12)
- Involvement of JAK-family tyrosine kinases in hematopoietin receptor signal transduction. (1994) (12)
- Direct phosphorylation of the IL-2 receptor Tac antigen epitope by protein kinase C. (1986) (12)
- Dissociation of human cytokine receptor expression and signal transduction. (1992) (12)
- Autoradiographic localization of T4 antigen, the HIV receptor, in human brain. (1987) (12)
- Cytokine regulation of protein phosphorylation. (1990) (11)
- Cyclosporin A inhibits induction of IL-2 receptor alpha chain expression by affecting activation of NF-kB-like factor(s) in cultured human T lymphocytes. (1990) (10)
- Characterization of the human immunodeficiency virus type 1 enhancer-binding proteins from the human T-cell line Jurkat. (1990) (10)
- Regulation of the interleukin 2 receptor complex tyrosine kinase activity in vitro. (1991) (10)
- Suppressor cell activity in tumor-bearing mice. III. Co-purification of a factor inhibiting cellular DNA synthesis and DNA polymerase activity. (1981) (10)
- Evidence for the common expression of neuroendocrine hormones and cytokines in the immune and central nervous systems (1988) (9)
- Hematopoietic growth-factor signal transduction and regulation of gene expression. (1990) (9)
- Human immunodeficiency virus glycoprotein ( gpl 20 ) induction of monocyte arachidonic acid metabolites and interleukin 1 (9)
- A bifunctional colchicinoid that binds to the androgen receptor (2007) (9)
- Relationship between Lymphokine and Opiatergic Modulation of Lymphocyte Proliferation (1986) (8)
- Characterization of a tyrosine kinase activity associated with the high-affinity interleukin 2 receptor complex. (1992) (8)
- Cancer Stem Cells: Purification and characterization of cancer stem cells (2009) (8)
- Interleukin 3 and phorbol ester stimulate tyrosine phosphorylation of overlapping substrate proteins (1989) (8)
- Modulation of E-receptor expression on activated T lymphocytes. (1986) (8)
- Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells. (2000) (7)
- Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPAR cross talk with NF- B and C/EBP (2007) (7)
- HIV receptor in brain and deduced peptides that block viral infectivity. (1988) (7)
- The Differentiation of Pancreatic Tumor-Initiating Cells by Vitronectin Can Be Blocked by Cilengitide (2013) (6)
- Molecular cloning of FKHRL1P2, a member of the developmentally regulated fork head domain transcription factor family. (1998) (5)
- Regulation of Protein Kinases and Gene Expression by Immunocytokines (1990) (5)
- Characterization of interleukin 1 receptors in brain. (1988) (5)
- Specific protein kinases modulated during T cell mitogenesis. Activity of a 55-kDa serine kinase is associated with growth arrest in human T cells. (1992) (5)
- Interleukin-2-dependent phosphorylation of the retinoblastoma-susceptibility-gene product p110-115RB in human T-cells. (1992) (5)
- Confirmed assignment of a novel human tyrosine kinase gene (JAK1A) to 1p32.3-->p31.3 by nonisotopic in situ hybridization. (1995) (4)
- Genomic Analysis of Invasive Human Bone Marrow Derived Mesenchymal Stem Cells (2013) (4)
- Survivin is not induced by novel taxanes. (2010) (4)
- The STATus of miR-21 in apoptosis (2007) (3)
- Retinoblastoma protein phosphorylation does not require activation of p34CDC2 protein kinase. (1992) (3)
- Chapter 17 Induction of Protein Phosphorylation during Leukocyte Activation (1990) (3)
- Two-dimensional analysis of interleukin 2-regulated tyrosine kinase activation mediated by the p70-75 β subunit of the interleukin 2 receptor (1989) (3)
- The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres. (2012) (3)
- Signalling by Cytokines (2005) (3)
- TUMOR-INDUCED DUALISTIC SUPPRESSOR CELL REGULATION: MACROPHAGES AND SUPPRESSOR T CELLS (1979) (3)
- The chemokine kidnapping receptor of HHV8. (1998) (3)
- EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis (2012) (2)
- Suppressor Cell Activity in Tumor-Bearing Mice (1978) (2)
- Visualization of human helper T lymphocyte differentiation antigen in primate brain (1988) (2)
- Leukemia Virus Type 3-Stat 5 Pathway in Malignant Growth of Functional Uncoupling of the Janus Kinase (2000) (2)
- Influence of Angle of Attack on Profile Drag and Flow Induced Vibrations of Parachute Suspension Lines (2017) (2)
- The low opioid consumption in Italy depends on late palliative care (2013) (2)
- Role of protein kinase C in lymphokine growth factor regulation of oncogene transcription (1986) (2)
- Mechanisms of cytokine signal transduction: IL-2, IL-4 and prolactin as hematopoietin receptor models. (1998) (1)
- Vasopressin and phorbol ester replacement of interleukin 2 requirement in immune interferon production: Cyclic GMP as the common second messenger (1982) (1)
- Interleukin-2 regulation of diadenosine 5',5'''-p1 p4-tetraphosphate (Ap4A) levels and DNA synthesis in cloned murine T lymphocytes. (1990) (1)
- Purification of the renaturable protein kinase PK55 by preparative isoelectric focusing and high performance electrophoretic chromatography and the generation of PK55 monoclonal antibodies by in vitro B cell stimulation. (1997) (1)
- Developments concerning the biochemical and molecular basis of IL-2 mediated T cell growth. (1986) (1)
- The Role of Kinase Activation and Gene Expression in the Action of Interleukin 2 (1989) (1)
- Conversion of normal host splenocytes to suppressor cells by tumor-induced suppressor T-cell-derived factor(s): cyclophosphamide treatment reverses inhibitory activity. (1983) (1)
- Inhitiation of alloantigen-specific cytotoxic t lympho- cyte responses by lymphocyte activation factor (laf). Abstr. (1979) (1)
- Effects ofManganese Superoxide Dismutase Silencingon Androgen Receptor Function and Gene Regulation : Implications for Castration-Resistant Prostate Cancer (2008) (0)
- Cancer Stem Cells: Preface (2009) (0)
- 15-Deoxy-#-Prostaglandin J2 Inhibits Transcriptional Activity of Estrogen Receptor-A via Covalent Modification of DNA-Binding Domain (2007) (0)
- Re: "Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women's health initiative (United States)". (2008) (0)
- Embryonic stem cell pathways and chemotherapy response: an unexplored route. (2013) (0)
- I : CHARACTERIZATION OF CANCER STEM CELLS 1 Purification and characterization of cancer stem cells (2009) (0)
- Abstract A58: Epigenetic regulation of CpG promoters by NF-kB pathway in invasive pancreatic cancer cells. (2011) (0)
- Interaction of protein phosphorylation systems induced by interleukin 2 and phorbol ester (1985) (0)
- Security Awareness Starts in IT (2001) (0)
- Modulation of hiv enhancer binding proteins detected by a new methodology (1988) (0)
- 162 POSTER Effects of SOD2 silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer (2008) (0)
- EffectsoftheSesquiterpeneLactoneParthenolideon ProstateTumor-InitiatingCells:An IntegratedMolecular ProfilingApproach (2009) (0)
- Cancer Stem Cells: Plate section (2009) (0)
- 1-Transformed Human T Cells Human T Cell Leukemia Virus Type 3-Stat5 Pathway in Malignant Growth of Functional Uncoupling of the Janus Kinase (2000) (0)
- COMMENT ON: BODY SIZE, WEIGHT CYCLING, AND RISK OF RENAL CELL CARCINOMA AMONG POSTMENOPAUSAL WOMEN : THE WOMEN'S HEALTH INITIATIVE (UNITED STATES). Authors' reply (2008) (0)
- TGFBR3 is lost in prostate cancer, contributing to malignant transformation. (2006) (0)
- Comprar Cancer Stem Cells | William L. Farrar | 9780521896283 | Cambridge University Press (2009) (0)
- Soluble tumor necrosis factor receptor: Inhibition of human (2005) (0)
- Erratum: Survivin is not induced by novel taxanes (Molecular Pharmaceutics (2010) 7: 6 (2216-2223)) (2011) (0)
- Detection of enhancer binding proteins recognizing the human immunodeficiency virus long terminal repeat by in situ gel retardation. (1989) (0)
- Long-TermRecoveryof Irradiated ProstateCancer (2012) (0)
- 3 - Identification of Intracellular Mediators of the Actions of Cytokines: Identifying Proteins Involved in Kinase Signaling Pathways (1993) (0)
- The emerging role of histone lysine demethylases in prostate cancer (2012) (0)
- Tumor-Induced Impairment of T-Cell-Independent B-Cell Blastogenesis and DNA Polymerase Activity 1 (1982) (0)
- Epigenetic Up-regulation of Gene Expression in KAS 6/1 Human Multiple Myeloma Cells. (2004) (0)
- Human immunodeficiency virus glycoprotein ( gpl 20 ) induction of monocyte arachidonic acid metabolites and interleukin 1 ( acquired immunodeficiency syndrome / prostaglandins / leukotrienes / CD 4 ) (0)
- Expression and Regulation of the IL-2β-Chain Receptor on CD3- Lymphocytes (1990) (0)
- Lymphohematopoietic factors and biological control mechanisms. (1990) (0)
- Characteristics of an inhibitor(s) of dna synthesis (ids) and dna polymerase (idp) alpha produced by suppressor t cell from fibrosarcoma-bearing mice. Abstr. (1978) (0)
- Regulation of Phosphorylation and Gene Expression in Cytotoxic Lymphocytes by Interleukin-2 (2018) (0)
- Protein Kinase and NF-Mitogen-ActivatedMacrophages : Role of p 38 Chemokine Production in Human Isoform b with Collagen UpRegulates Activation of Discoidin Domain Receptor 1 Faure and (2004) (0)
- Evidence for a Kinase Cascade Stimulated by Interleukin 2 in Cytotoxic T Cell Clones (1988) (0)
- Our mistake (1987) (0)
- Subject Index, Vol. 69, 1995 (2004) (0)
- LARRY M. WAHL*t, MARTA L. CORCORAN*, STEPHEN W. PYLEt, LARRY 0. ARTHURt, (2016) (0)
- Regulation of c-myc and ornithine decarboxylase expression by distinct protein kinase systems in IL-3-dependent myeloid cells. (1991) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William L. Farrar?
William L. Farrar is affiliated with the following schools:
